Research News and Research

RSS

BioCision, Biohit announce co-promotion program

BioCision LLC today announced that it has agreed to a co-promotion program with Biohit Inc.. Biohit's ErgoTube microcentrifuge tubes will now be branded and sold by both Biohit Inc. and BioCision. In addition, Biohit Inc. will cross-promote BioCision's highly thermo-conductive CoolRack microfuge tube racks for use in combination with ErgoTubes.

31 Mar 2010

ChromaDex records revenue of $5.78M for 2009

ChromaDex Corporation, a leader in phytochemical reference standards and contract research, today announced financial results for the Fiscal Year ending January 2, 2010. On a reported basis calculated in accordance with U.S. Generally Accepted Accounting Principles (U.S. GAAP), ChromaDex announced a net loss attributable to common stockholders of $0.03 per share for the one year period ended January 2, 2010. As of January 2, 2010, cash, cash equivalents, and marketable securities totaled $471,378.

31 Mar 2010

RXi Pharmaceuticals reports net loss of 28% for 2009

RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today reported financial results for the fourth quarter and year ended December 31, 2009.

31 Mar 2010

Changes in daily behavior can influence remembering to take daily medication

For many people, remembering to take a daily medication can be the difference between life and death. Yet, people forget all the time. Now a landmark study from North Carolina State University has found that changes in daily behavior have a significant effect on whether we remember to take our medication - and that these changes influence older and younger adults differently. That's good news, because it means there's something we can do about it.

31 Mar 2010

Funds raised at CASMA's spring conference to benefit The Montréal Children's Hospital

Mondial Assistance and the Computerized Airline Sales and Marketing Association announced today that a fundraiser held during a reception at CASMA's spring conference in Montréal raised enough money to purchase a saturation/end tidal carbon dioxide monitor for the Department of Anesthesia at The Montréal Children's Hospital.

31 Mar 2010

BBSRC, NSF to hold intensive week long facilitated workshop to enhance photosynthesis

Leading bioscience funding bodies in the UK and USA announce plans to promote scientific proposals in the potentially transformational area of enhanced photosynthesis.

31 Mar 2010

Social networks can spread misunderstandings about proper use of antibiotics

Misunderstandings about proper use of antibiotics have the potential to spread widely through social networks such as Twitter, according to a report in the April issue of AJIC: American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology, Inc. (APIC).

31 Mar 2010

SANUWAVE Health reports net loss of $2.7M for three months ended December 31, 2009

SANUWAVE Health, Inc., an emerging medical technology company focused on regenerative medicine, reports its financial results for the fourth quarter and full year ended December 31, 2009, and on its progress for the year.

31 Mar 2010

Fully integrated medical curriculum proves beneficial for minority students

Of all the licensing exams along the way to becoming an M.D., the Step 1 is notorious for having the worst national passage rate. By adopting a fully integrated medical curriculum in lieu of the traditional academic model, the University of Texas Medical Branch has seen a dramatic drop over the course of a decade in the failure rate, with underrepresented minority students benefiting the most, according to new research that will be presented April 30, 2010 at the annual meeting of the American Educational Research Association.

31 Mar 2010

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

31 Mar 2010

IVAX Diagnostics reports net revenue of $4.5M for quarter ended December 31, 2009

IVAX Diagnostics, Inc., a fully integrated in vitro diagnostics company, reports its financial results for the fourth quarter and full year ended December 31, 2009.

31 Mar 2010

DATATRAK International reports 31% decrease in revenue for fourth-quarter 2009

DATATRAK International, Inc., a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced its operating results for the fourth quarter and full year of 2009.

31 Mar 2010

T-cell cytolytic activity may be effective in clearing HBV infection

Co-infection with human immunodeficiency virus (HIV) and hepatitis B virus (HBV) poses a treatment challenge. In Western Europe and the United States, chronic HBV infection has been found in 6%󈝺% of HIV-positive patients and this co-infection is well known to be associated with increased liver-related morbidity and mortality. However, factors associated with HBV surface antigen (HbsAg) loss in HIV and HBV co-infected patients remain unclear.

31 Mar 2010

National Doctors' Day: St. Jude Children's Research Hospital honors physicians and staff

As physicians nationwide are acknowledged for their talent, sacrifice and courage on National Doctors' Day, St. Jude Children's Research Hospital honors its more than 230 staff and consulting physicians who strive to fulfill the hospital's mission each day.

31 Mar 2010

Recipients of Pfizer Canada's third Neuropathic Pain Research Awards Competition announced

Pfizer Canada is pleased to announce the recipients of its third Neuropathic Pain Research Awards Competition, which aims to fund and support Canadian innovation within independent neuropathic pain research in the areas of basic biomedical, clinical and health sciences.

31 Mar 2010

2010 BIO International Convention to discuss issues that impact drug discovery and development

The 2010 BIO International Convention will feature a robust health and medical program highlighting the latest scientific breakthroughs and policy and business development issues that impact drug discovery and development. Hosted by the Biotechnology Industry Organization, the Convention will be held May 3-6, 2010 in Chicago, Ill. at McCormick Place.

31 Mar 2010

New legislation will increase access to health care, says DDI

Will the newly signed health care legislation create a major shift in how pharmaceutical brand decisions are made? The bill will increase access to health insurance, but many believe the practice of medicine is already in transition, and the bill signed by President Obama will simply accelerate changes already being implemented.

31 Mar 2010

Fat-rich breakfast may help prevent metabolic syndrome, says study

The age-old maxim "Eat breakfast like a king, lunch like a prince and dinner like a pauper" may in fact be the best advice to follow to prevent metabolic syndrome, according to a new University of Alabama at Birmingham (UAB) study.

31 Mar 2010

Cryo-Cell International, MOSI partner to develop educational exhibit on stem cells and regenerative science

Cryo-Cell International Inc., a global leader of innovative stem cell solutions and stem cell cryopreservation services, today announced plans to partner with Museum of Science & Industry (MOSI) in the development and launch of an interactive educational exhibit on stem cells and regenerative science. Cryo-Cell is one of the most established private family cord blood banks and is a pioneer in the stem cell industry.

31 Mar 2010

Investment report on Sunesis Pharmaceuticals

StockPreacher.com announces an investment report featuring Sunesis Pharmaceuticals Inc.. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

31 Mar 2010

Research News and Research

BioCision, Biohit announce co-promotion program

ChromaDex records revenue of $5.78M for 2009

RXi Pharmaceuticals reports net loss of 28% for 2009

Changes in daily behavior can influence remembering to take daily medication

Funds raised at CASMA's spring conference to benefit The Montréal Children's Hospital

BBSRC, NSF to hold intensive week long facilitated workshop to enhance photosynthesis

Social networks can spread misunderstandings about proper use of antibiotics

SANUWAVE Health reports net loss of $2.7M for three months ended December 31, 2009

Fully integrated medical curriculum proves beneficial for minority students

Rosetta Genomics reports revenues of $150,000 for full-year 2009

IVAX Diagnostics reports net revenue of $4.5M for quarter ended December 31, 2009

DATATRAK International reports 31% decrease in revenue for fourth-quarter 2009

T-cell cytolytic activity may be effective in clearing HBV infection

National Doctors' Day: St. Jude Children's Research Hospital honors physicians and staff

Recipients of Pfizer Canada's third Neuropathic Pain Research Awards Competition announced

2010 BIO International Convention to discuss issues that impact drug discovery and development

New legislation will increase access to health care, says DDI

Fat-rich breakfast may help prevent metabolic syndrome, says study

Cryo-Cell International, MOSI partner to develop educational exhibit on stem cells and regenerative science

Investment report on Sunesis Pharmaceuticals

New Approach Methodologies, the 3Rs and Multimodal Imaging in Preclinical Research - eBook eBook

Latest eBooks

A practical guide to lipid nanoparticle formulation and resizing

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence